Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how severe thalassemia is in people living in Upper Egypt. Thalassemia is a blood disorder that affects the body's ability to produce healthy red blood cells, and this study aims to look at various factors, not just how often patients need blood transfusions. By gathering this information, the researchers hope to improve the care and quality of life for those affected by thalassemia.
The trial is not yet recruiting participants but will include children and adolescents aged 18 months to 18 years who have thalassemia. Unfortunately, children without thalassemia will not be eligible to join. If you or your child participates, you can expect to share health information and undergo evaluations that will help researchers better understand the impact of thalassemia. This study is an important step toward improving treatment options and support for those living with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Children and adolescents aged from 18 month to 18 year old. Those with thalassemia
- Exclusion Criteria:
- • Non Thalassaemia children
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Shereen Mansour Galal, Associate professor
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported